Skip to main content

National investment case development for pathogen genomics.

Publication ,  Journal Article
Khoo, YK; Wulandari, S; Getchell, M; Moe, L; Kumar, SS; Liu, EJ; Sun, Y; Pang, J; Mishra, S; Clapham, H; Marais, B; Sintchenko, V; Pronyk, PM ...
Published in: Cell genomics
March 2025

Sustaining and expanding genomic surveillance capacity requires broader investment in genomics that target both novel and pandemic pathogens. Currently, there is no standardized methodology to evaluate the cost and benefit of a multi-pathogen surveillance system. We propose a framework for pathogen genomic surveillance that links public health and systems considerations to a stepwise approach.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Cell genomics

DOI

EISSN

2666-979X

ISSN

2666-979X

Publication Date

March 2025

Volume

5

Issue

3

Start / End Page

100781

Related Subject Headings

  • Public Health
  • Pandemics
  • Investments
  • Humans
  • Genomics
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Khoo, Y. K., Wulandari, S., Getchell, M., Moe, L., Kumar, S. S., Liu, E. J., … Pronyk, P. M. (2025). National investment case development for pathogen genomics. Cell Genomics, 5(3), 100781. https://doi.org/10.1016/j.xgen.2025.100781
Khoo, Yoong Khean, Suci Wulandari, Marya Getchell, La Moe, Shurendar Selva Kumar, Elyssa Jiawen Liu, Yimei Sun, et al. “National investment case development for pathogen genomics.Cell Genomics 5, no. 3 (March 2025): 100781. https://doi.org/10.1016/j.xgen.2025.100781.
Khoo YK, Wulandari S, Getchell M, Moe L, Kumar SS, Liu EJ, et al. National investment case development for pathogen genomics. Cell genomics. 2025 Mar;5(3):100781.
Khoo, Yoong Khean, et al. “National investment case development for pathogen genomics.Cell Genomics, vol. 5, no. 3, Mar. 2025, p. 100781. Epmc, doi:10.1016/j.xgen.2025.100781.
Khoo YK, Wulandari S, Getchell M, Moe L, Kumar SS, Liu EJ, Sun Y, Pang J, Mishra S, Clapham H, Marais B, Sintchenko V, de Alwis R, Hipgrave D, Pronyk PM. National investment case development for pathogen genomics. Cell genomics. 2025 Mar;5(3):100781.

Published In

Cell genomics

DOI

EISSN

2666-979X

ISSN

2666-979X

Publication Date

March 2025

Volume

5

Issue

3

Start / End Page

100781

Related Subject Headings

  • Public Health
  • Pandemics
  • Investments
  • Humans
  • Genomics